(Q54330859)

27 May 2018

title

UHRF1 promotes cell growth and metastasis through repression of p16(ink⁴a) in colorectal cancer. (English)

1 reference

27 May 2018

1 reference

1 reference

Feng Wang

1

1 reference

27 May 2018

Yong-Zhi Yang

2

1 reference

27 May 2018

Chen-Zhang Shi

3

1 reference

27 May 2018

Peng Zhang

4

1 reference

27 May 2018

Mary Pat Moyer

5

1 reference

27 May 2018

Hui-Zhen Zhang

6

1 reference

27 May 2018

Yang Zou

7

1 reference

27 May 2018

Huan-Long Qin

8

1 reference

27 May 2018

publication date

5 January 2012

1 reference

27 May 2018

Annals of Surgical Oncology

published in

1 reference

27 May 2018

volume

19

1 reference

27 May 2018

issue

8

1 reference

27 May 2018

page(s)

2753-2762

1 reference

27 May 2018

https://scigraph.springernature.com/pub.10.1245/s10434-011-2194-1

exact match

0 references

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2194-1

Time trends in cancer mortality in China: 1987-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2194-1

ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2194-1

The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2194-1

UHRF1, a modular multi-domain protein, regulates replication-coupled crosstalk between DNA methylation and histone modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2194-1

The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future?

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2194-1

Drug discovery targeting epigenetic codes: the great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2194-1

Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2194-1

The staging of colorectal cancer: 2004 and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2194-1

Value of staining intensity in the interpretation of immunohistochemistry for tumor markers in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2194-1

Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2194-1

NCM460, a normal human colon mucosal epithelial cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2194-1

Signal transduction pathways mediating neurotensin-stimulated interleukin-8 expression in human colonocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2194-1

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2194-1

UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2194-1

UHRF1 is a novel diagnostic marker of lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2194-1

Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2194-1

Critical role of the ubiquitin ligase activity of UHRF1, a nuclear RING finger protein, in tumor cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2194-1

UHRF1-mediated tumor suppressor gene inactivation in nonsmall cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2194-1

ICBP90, a novel methyl K9 H3 binding protein linking protein ubiquitination with heterochromatin formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2194-1

UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2194-1

The regulation of INK4/ARF in cancer and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2194-1

Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2194-1

Adenovirus-mediated gene transfer of P16INK4/CDKN2 into bax-negative colon cancer cells induces apoptosis and tumor regression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2194-1

K-ras and p16 aberrations confer poor prognosis in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-011-2194-1

10.1245/S10434-011-2194-1

21 January 2018

Identifiers

DOI

1 reference

27 May 2018

Dimensions Publication ID

0 references

1 reference

27 May 2018